Talampanel

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTalampanel
Drug Alias Nametalampanelum他仑帕奈AmpanelKinampaGYKI-53773 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsCNS Embryonal TumorAmyotrophic Lateral SclerosisDyskinesias +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)National Institute Of Neurological Disorders And StrokeTeva Branded Pharmaceutical Products R&D Inc
Active IndicationsN/A
Inactive IndicationsCNS Embryonal TumorAmyotrophic Lateral SclerosisDyskinesias +[9] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG